Neurotensin-Deficient Mice Have Deficits in Prepulse Inhibition: Restoration by Clozapine but Not Haloperidol, Olanzapine, or Quetiapine
Open Access
- 1 October 2005
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 315 (1) , 256-264
- https://doi.org/10.1124/jpet.105.087437
Abstract
Prepulse inhibition (PPI) of the acoustic startle reflex is a commonly used measure of preattentive sensorimotor gating. Disrupted PPI in rodents represents an animal model of the sensorimotor gating deficits characteristic of schizophrenia. The neurotensin (NT) system is implicated in the pathophysiology of schizophrenia, and NT has been hypothesized to act as an endogenous antipsychotic. In rats, NT receptor agonists restore PPI disrupted by dopamine receptor agonists and N-methyl-d-aspartate receptor antagonists, and pretreatment with an NT receptor antagonist blocks restoration of isolation rearing induced deficits in PPI by some antipsychotic drugs. The current studies further scrutinized the role of the NT system in the regulation of PPI and in antipsychotic drug-induced restoration of PPI using NT-null mutant mice (NT-/-). NT-/- mice exhibited significantly higher pulse alone startle amplitudes and disrupted PPI compared with NT+/+ mice. Haloperidol (0.1 mg/kg) and quetiapine (0.5 mg/kg) administered 30 min before PPI testing significantly increased PPI in NT+/+ mice but had no effect on PPI in NT-/- mice. In contrast, clozapine (1.0 mg/kg) significantly increased PPI in both NT-/- and NT+/+ mice, whereas olanzapine (0.5 mg/kg) had no effect on PPI in either NT-/- or NT+/+ mice. In a separate experiment, amphetamine (2.0 mg/kg i.p.) significantly disrupted PPI in NT+/+ mice but not NT-/- mice. These results provide evidence that the effects of antipsychotic drugs (APDs) may be differentially affected by the state of NT neurotransmission and, moreover, that APDs differ in their dependence on an intact NT system.Keywords
This publication has 44 references indexed in Scilit:
- Neurotensin Receptor Antagonist SR 142948A Alters Fos Expression and Extrapyramidal Side Effect Profile of Typical and Atypical Antipsychotic DrugsNeuropsychopharmacology, 2004
- Blockade of neurotensin receptors affects differently hypo-locomotion and catalepsy induced by haloperidol in miceNeuropharmacology, 2004
- Neurotensin, Schizophrenia, and Antipsychotic Drug ActionPublished by Elsevier ,2004
- Neurotensin: an endogenous antipsychotic?Current Opinion in Pharmacology, 2002
- Chronic Blockade of Neurotensin Receptors Strongly Reduces Sensitized, but Not Acute, Behavioral Response to D-amphetamineNeuropsychopharmacology, 2002
- Role of Endogenous Neurotensin in the Behavioral and Neuroendocrine Effects of CocaineNeuropsychopharmacology, 1998
- Preexposure to, but Not Cotreatment with, the Neurotensin Antagonist SR 48692 Delays the Development of Cocaine SensitizationNeuropsychopharmacology, 1994
- Prepulse inhibition of the startle response in mice: Relationship to hearing loss and auditory system plasticity.Behavioral Neuroscience, 1994
- Reduced CSF neurotensin concentration in drug-free schizophrenic patientsSchizophrenia Research, 1988
- Disorders of attention and perception in early schizophreniaPsychology and Psychotherapy: Theory, Research and Practice, 1961